The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma

被引:3
|
作者
Zhang, Lishuo [1 ]
Di, Longjiang [2 ]
Liu, Jinhui [3 ]
Lei, Xianli [4 ]
Gu, Maoli [1 ]
Zhang, Wenjing [3 ]
Wang, Yufu [3 ]
机构
[1] Harbin Med Univ, Dept Urol, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China
[2] Southern Med Univ, Coll Basic Med, Guangzhou, Guangdong, Peoples R China
[3] Harbin Med Univ, Affiliated Hosp 2, Harbin, Heilongjiang, Peoples R China
[4] Harbin Med Univ, Harbin, Heilongjiang, Peoples R China
基金
中国国家自然科学基金;
关键词
clear cell renal cell carcinoma; long non-coding RNA; cuproptosis; prognosis; immunotherapy; CLASSIFICATION;
D O I
10.3389/fgene.2023.1039813
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Cuproptosis is a new form of cell death, the second form of metal ion-induced cell death defined after ferroptosis. Recently, cuproptosis has been suggested to be associated with tumorigenesis. However, the relationship between cuproptosis and patient prognosis in clear cell renal cell carcinoma (ccRCC) in the context of immunotherapy remains unknown. The aim of this study was to investigate the correlation between cuproptosis-related long non-coding RNA (lncRNA) and ccRCC in terms of immunity as well as prognosis. Clinical information on lncRNAs associated with differences in cuproptosis genes in ccRCC and normal tissues was collected from The Cancer Genome Atlas (TCGA) dataset. Univariate Cox regression was used to screen lncRNAs. A total of 11 lncRNAs closely associated with cuproptosis were further screened and established using the least absolute shrinkage and selection operator (LASSO) algorithm and multivariate Cox regression, and the samples were randomly divided into training and test groups. A risk prognostic model was constructed using the training group, and the model was validated using the test group. We investigated the predictive ability of the prognostic risk model in terms of clinical prognosis, tumor mutation, immune escape, immunotherapy, tumor microenvironment, immune infiltration levels, and tumor drug treatment of ccRCC. Using the median risk score, patients were divided into low and high-risk groups. Kaplan-Meier curves showed that the overall survival (OS) of patients in the high-risk group was significantly worse than low-risk group (p < 0.001). Receiver operating characteristic (ROC) curves further validated the reliability of our model. The model consistently and accurately predicted prognosis at 1, 3, and 5 years, with an AUC above 0.7. Tumor cell genes generally precede morphological abnormalities; therefore, the model we constructed can effectively compensate for the traditional method of evaluating the prognosis of patients with renal cancer, and our model was also clinically meaningful in predicting ccRCC staging. In addition, lower model risk scores determined by mutational load indicated a good chance of survival. The high-risk group had greater recruitment of immune cells, while the anti-immune checkpoint immunotherapy was less efficacious overall than that of the low-risk group. Tumor and immune-related pathways were enriched, and anti-tumor agents were selected to improve the survival of ccRCC. This prognostic risk model is based on the levels of cuproptosis-associated lncRNAs and provides a new perspective in the clinical assessment and precise treatment of ccRCC.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] A novel coagulation-related lncRNA predicts the prognosis and immune of clear cell renal cell carcinoma
    Wu, Wensong
    Chang, Fan
    Zhang, Jianghui
    Tang, Shuai
    Lv, Zhen
    Chen, Fangmin
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [42] Novel immune-related signature based on immune cells for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma
    Zhou, Libin
    Fang, Hualong
    Yin, Min
    Long, Huimin
    Weng, Guobin
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (06)
  • [43] A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma
    Chen, Siteng
    Zhang, Encheng
    Guo, Tuanjie
    Shao, Jialiang
    Wang, Tao
    Zhang, Ning
    Wang, Xiang
    Zheng, Junhua
    BMC CANCER, 2022, 22 (01)
  • [44] A novel ferroptosis-related gene signature associated with cell cycle for prognosis prediction in patients with clear cell renal cell carcinoma
    Siteng Chen
    Encheng Zhang
    Tuanjie Guo
    Jialiang Shao
    Tao Wang
    Ning Zhang
    Xiang Wang
    Junhua Zheng
    BMC Cancer, 22
  • [45] A Notch signaling-related lncRNA signature for predicting prognosis and therapeutic response in clear cell renal cell carcinoma
    Zhang, Lulu
    Li, Yulei
    Cai, Bin
    Chen, Jiajun
    Zhao, Keyuan
    Li, Mengyao
    Lang, Juan
    Wang, Kaifang
    Pan, Shouhua
    Zhu, Ke
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [46] Identification of a Three-Glycolysis-Related lncRNA Signature Correlated With Prognosis and Metastasis in Clear Cell Renal Cell Carcinoma
    Li, Tinghao
    Tong, Hang
    Zhu, Junlong
    Qin, Zijia
    Yin, Siwen
    Sun, Yan
    Liu, Xudong
    He, Weiyang
    FRONTIERS IN MEDICINE, 2022, 8
  • [47] A Notch signaling-related lncRNA signature for predicting prognosis and therapeutic response in clear cell renal cell carcinoma
    Lulu Zhang
    Yulei Li
    Bin Cai
    Jiajun Chen
    Keyuan Zhao
    Mengyao Li
    Juan Lang
    Kaifang Wang
    Shouhua Pan
    Ke Zhu
    Scientific Reports, 13
  • [48] Construction of the Six-lncRNA Prognosis Signature as a Novel Biomarker in Esophageal Squamous Cell Carcinoma
    Zheng, Ze-Jun
    Li, Yan-Shang
    Zhu, Jun-De
    Zou, Hai-Ying
    Fang, Wang-Kai
    Cui, Yi-Yao
    Xie, Jian-Jun
    FRONTIERS IN GENETICS, 2022, 13
  • [49] A Novel Tumor Mutation Burden Related lncRNA Signature Identified Prognosis and Tumor Immune Microenvironment Features in Clear Cell Renal Cell Carcinoma
    Lin, Lin
    Wu, Xiao-Hui
    Zhu, Jun-Ming
    Chen, Shao-Hao
    Chen, Ye-Hui
    Lin, Fei
    Xue, Xue-Yi
    Wei, Yong
    Xu, Ning
    Zheng, Qing-Shui
    Sun, Xiong-Lin
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2023, 26 (08) : 1503 - 1518
  • [50] A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma
    Mei, Wangli
    Liu, Xiang
    Jia, Xuyang
    Jin, Liang
    Xin, Shiyong
    Sun, Xianchao
    Zhang, Jiaxin
    Zhang, Bihui
    Chen, Yilai
    Che, Jianping
    Ma, Weiguo
    Ye, Lin
    FRONTIERS IN GENETICS, 2022, 13